FILENAME	SEQ	COMPOUND_NAME	MOLECULEMASS	INSTRUMENT	IONSOURCE	EXTRACTSCAN	SMILES	INCHI	INCHIAUX	CHARGE	IONMODE	PUBMED	ACQUISITION	EXACTMASS	DATACOLLECTOR	ADDUCT	INTEREST	LIBQUALITY	GENUS	SPECIES	STRAIN	CASNUMBER	PI
MSV000084479/peak/mzXML/GNPS00005_D10_n.mzXML	*.*	GLYCEROL 3-PHOSPHATE	171.006398638	Orbitrap	ESI	39	OC[C@@H](O)COP(O)(O)=O	InChI=1S/C3H9O6P/c4-1-3(5)2-9-10(6,7)8/h3-5H,1-2H2,(H2,6,7,8)/t3-/m1/s1	N/A	-1	Negative		Commercial	172.013674638	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	29849-82-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B2_n.mzXML	*.*	AMINOADIPATE	160.06153183200001	Orbitrap	ESI	19	NC(CCCC(O)=O)C(O)=O	InChI=1S/C6H11NO4/c7-4(6(10)11)2-1-3-5(8)9/h4H,1-3,7H2,(H,8,9)(H,10,11)	N/A	-1	Negative		Commercial	161.068807832	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	542-32-5	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B1_p.mzXML	*.*	TRYPTAMINE	161.10732438399998	Orbitrap	ESI	26	NCCC1=CNC2=CC=CC=C12	InChI=1S/C10H12N2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6,11H2	N/A	1	Positive		Commercial	160.100048384	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	61-54-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C1_p.mzXML	*.*	FUCOSE	187.057691484	Orbitrap	ESI	71	C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O	InChI=1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3+,4+,5-,6?/m0/s1	N/A	1	Positive		Commercial	164.068473484	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	2438-80-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G11_p.mzXML	*.*	GALACTITOL	205.068256168	Orbitrap	ESI	19	OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO	InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4+,5+,6-	N/A	1	Positive		Commercial	182.079038168	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	608-66-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G5_n.mzXML	*.*	METHIONINE SULFOXIMINE	179.049587244	Orbitrap	ESI	24	CS(=N)(=O)CCC(N)C(O)=O	InChI=1S/C5H12N2O3S/c1-11(7,10)3-2-4(6)5(8)9/h4,7H,2-3,6H2,1H3,(H,8,9)	N/A	-1	Negative		Commercial	180.056863244	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	15985-39-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C12_n.mzXML	*.*	3,4-DIHYDROXYPHENYLACETATE	357.05918347200003	Orbitrap	ESI	29	OC(=O)CC1=CC=C(O)C(O)=C1	InChI=1S/C8H8O4/c9-6-2-1-5(3-7(6)10)4-8(11)12/h1-3,9-10H,4H2,(H,11,12)	N/A	-1	Negative		Commercial	168.042258736	Kelly Weldon	2M-2H+Na	N/A	1	N/A	N/A	N/A	102-32-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B9_n.mzXML	*.*	N-ACETYLCYSTEINE	162.023038148	Orbitrap	ESI	24	CC(=O)N[C@@H](CS)C(O)=O	InChI=1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1	N/A	-1	Negative		Commercial	163.030314148	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	616-91-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B3_p.mzXML	*.*	N-METHYLGLUTAMATE	162.076083832	Orbitrap	ESI	24	CNC(CCC(=O)O)C(=O)O	InChI=1S/C6H11NO4/c1-7-4(6(10)11)2-3-5(8)9/h4,7H,2-3H2,1H3,(H,8,9)(H,10,11)	N/A	1	Positive		Commercial	161.068807832	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	6753-62-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B3_p.mzXML	*.*	N-METHYLGLUTAMATE	144.064967832	Orbitrap	ESI	26	CNC(CCC(=O)O)C(=O)O	InChI=1S/C6H11NO4/c1-7-4(6(10)11)2-3-5(8)9/h4,7H,2-3H2,1H3,(H,8,9)(H,10,11)	N/A	1	Positive		Commercial	161.068807832	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	6753-62-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B4_p.mzXML	*.*	INDOLE-3-ETHANOL	162.091339972	Orbitrap	ESI	26	OCCC1=CNC2=CC=CC=C12	InChI=1S/C10H11NO/c12-6-5-8-7-11-10-4-2-1-3-9(8)10/h1-4,7,11-12H,5-6H2	N/A	1	Positive		Commercial	161.084063972	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	526-55-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B4_p.mzXML	*.*	INDOLE-3-ETHANOL	144.080223972	Orbitrap	ESI	20	OCCC1=CNC2=CC=CC=C12	InChI=1S/C10H11NO/c12-6-5-8-7-11-10-4-2-1-3-9(8)10/h1-4,7,11-12H,5-6H2	N/A	1	Positive		Commercial	161.084063972	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	526-55-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B4_p.mzXML	*.*	INDOLE-3-ETHANOL	184.073281972	Orbitrap	ESI	27	OCCC1=CNC2=CC=CC=C12	InChI=1S/C10H11NO/c12-6-5-8-7-11-10-4-2-1-3-9(8)10/h1-4,7,11-12H,5-6H2	N/A	1	Positive		Commercial	161.084063972	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	526-55-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F5_p.mzXML	*.*	SEROTONIN	177.10223900399998	Orbitrap	ESI	27	NCCC1=CNC2=CC=C(O)C=C12	InChI=1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2	N/A	1	Positive		Commercial	176.094963004	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	153-98-0	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F5_p.mzXML	*.*	SEROTONIN	199.084181004	Orbitrap	ESI	33	NCCC1=CNC2=CC=C(O)C=C12	InChI=1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2	N/A	1	Positive		Commercial	176.094963004	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	153-98-0	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D3_n.mzXML	*.*	PYRIDOXINE	168.066617212	Orbitrap	ESI	24	CC1=NC=C(CO)C(CO)=C1O	InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3	N/A	-1	Negative		Commercial	169.073893212	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	65-23-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C11_p.mzXML	*.*	URATE	169.035615988	Orbitrap	ESI	50	O=C1NC2=C(N1)C(=O)NC(=O)N2	InChI=1S/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H4,6,7,8,9,10,11,12)	N/A	1	Positive		Commercial	168.028339988	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	69-93-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H4_p.mzXML	*.*	3,4 DIHYDROXYMANDELATE	167.033333356	Orbitrap	ESI	21	OC(C(O)=O)C1=CC=C(O)C(O)=C1	InChI=1S/C8H8O5/c9-5-2-1-4(3-6(5)10)7(11)8(12)13/h1-3,7,9-11H,(H,12,13)	N/A	1	Positive		Commercial	184.037173356	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	775-01-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H4_p.mzXML	*.*	3,4 DIHYDROXYMANDELATE	149.023309356	Orbitrap	ESI	36	OC(C(O)=O)C1=CC=C(O)C(O)=C1	InChI=1S/C8H8O5/c9-5-2-1-4(3-6(5)10)7(11)8(12)13/h1-3,7,9-11H,(H,12,13)	N/A	1	Positive		Commercial	184.037173356	Kelly Weldon	M-2H2O+H	N/A	1	N/A	N/A	N/A	775-01-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B8_n.mzXML	*.*	5-HYDROXYLYSINE	161.093166308	Orbitrap	ESI	22	NC[C@H](O)CC[C@H](N)C(O)=O	InChI=1S/C6H14N2O3/c7-3-4(9)1-2-5(8)6(10)11/h4-5,9H,1-3,7-8H2,(H,10,11)/t4-,5+/m1/s1	N/A	-1	Negative		Commercial	162.100442308	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	13204-98-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H12_p.mzXML	*.*	KYNURENATE	190.049869084	Orbitrap	ESI	26	OC(=O)C1=CC(=O)C2=CC=CC=C2N1	InChI=1S/C10H7NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-5H,(H,11,12)(H,13,14)	N/A	1	Positive		Commercial	189.042593084	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	492-27-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H9_p.mzXML	*.*	N-ALPHA-ACETYLLYSINE	189.123368372	Orbitrap	ESI	26	CC(=O)NC(CCCCN)C(O)=O	InChI=1S/C8H16N2O3/c1-6(11)10-7(8(12)13)4-2-3-5-9/h7H,2-5,9H2,1H3,(H,10,11)(H,12,13)	N/A	1	Positive		Commercial	188.116092372	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	1946-82-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H9_p.mzXML	*.*	N-ALPHA-ACETYLLYSINE	211.105310372	Orbitrap	ESI	32	CC(=O)NC(CCCCN)C(O)=O	InChI=1S/C8H16N2O3/c1-6(11)10-7(8(12)13)4-2-3-5-9/h7H,2-5,9H2,1H3,(H,10,11)(H,12,13)	N/A	1	Positive		Commercial	188.116092372	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	1946-82-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A8_p.mzXML	*.*	N-ACETYLPROLINE	158.081169212	Orbitrap	ESI	23	CC(=O)N1CCCC1C(=O)O	InChI=1S/C7H11NO3/c1-5(9)8-4-2-3-6(8)7(10)11/h6H,2-4H2,1H3,(H,10,11)	N/A	1	Positive		Commercial	157.073893212	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	68-95-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A8_p.mzXML	*.*	N-ACETYLPROLINE	180.063111212	Orbitrap	ESI	22	CC(=O)N1CCCC1C(=O)O	InChI=1S/C7H11NO3/c1-5(9)8-4-2-3-6(8)7(10)11/h6H,2-4H2,1H3,(H,10,11)	N/A	1	Positive		Commercial	157.073893212	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	68-95-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B7_p.mzXML	*.*	3-HYDROXYMETHYLGLUTARATE	185.04204142	Orbitrap	ESI	21	CC(O)(CC(O)=O)CC(O)=O	InChI=1S/C6H10O5/c1-6(11,2-4(7)8)3-5(9)10/h11H,2-3H2,1H3,(H,7,8)(H,9,10)	N/A	1	Positive		Commercial	162.05282342	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	503-49-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F6_p.mzXML	*.*	N-FORMYL-L-METHIONINE	200.035182212	Orbitrap	ESI	29	CSCC[C@@H](NC=O)C(O)=O	InChI=1S/C6H11NO3S/c1-11-3-2-5(6(9)10)7-4-8/h4-5H,2-3H2,1H3,(H,7,8)(H,9,10)/t5-/m1/s1	N/A	1	Positive		Commercial	177.045964212	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	4289-98-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B5_p.mzXML	*.*	L-CARNITINE	162.11246934	Orbitrap	ESI	19	C[N+](C)(C)C[C@H](O)CC([O-])=O	InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m1/s1	N/A	1	Positive		Commercial	161.10519334	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	6645-46-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B5_p.mzXML	*.*	L-CARNITINE	184.09441134	Orbitrap	ESI	26	C[N+](C)(C)C[C@H](O)CC([O-])=O	InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m1/s1	N/A	1	Positive		Commercial	161.10519334	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	6645-46-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D4_n.mzXML	*.*	NORADRENALINE	168.066617212	Orbitrap	ESI	25	NC[C@H](O)C1=CC(O)=C(O)C=C1	InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1	N/A	-1	Negative		Commercial	169.073893212	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	51-41-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A10_n.mzXML	*.*	ALLANTOIN	157.036714052	Orbitrap	ESI	21	NC(=O)NC1NC(=O)NC1=O	InChI=1S/C4H6N4O3/c5-3(10)6-1-2(9)8-4(11)7-1/h1H,(H3,5,6,10)(H2,7,8,9,11)	N/A	-1	Negative		Commercial	158.043990052	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	97-59-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A3_p.mzXML	*.*	HISTIDINE	156.076752528	Orbitrap	ESI	27	N[C@@H](CC1=CNC=N1)C(O)=O	InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1	N/A	1	Positive		Commercial	155.069476528	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	5934-29-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A3_p.mzXML	*.*	HISTIDINE	178.058694528	Orbitrap	ESI	34	N[C@@H](CC1=CNC=N1)C(O)=O	InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1	N/A	1	Positive		Commercial	155.069476528	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	5934-29-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A3_p.mzXML	*.*	HISTIDINE	311.146229056	Orbitrap	ESI	105	N[C@@H](CC1=CNC=N1)C(O)=O	InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1	N/A	1	Positive		Commercial	155.069476528	Kelly Weldon	2M+H	N/A	1	N/A	N/A	N/A	5934-29-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H3_n.mzXML	*.*	EPINEPHRINE	182.082267276	Orbitrap	ESI	23	CNC[C@H](O)C1=CC=C(O)C(O)=C1	InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1	N/A	-1	Negative		Commercial	183.089543276	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	51-43-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E4_p.mzXML	*.*	SHIKIMATE	197.04204142	Orbitrap	ESI	23	O[C@@H]1CC(=C[C@@H](O)[C@H]1O)C(O)=O	InChI=1S/C7H10O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1,4-6,8-10H,2H2,(H,11,12)/t4-,5-,6-/m1/s1	N/A	1	Positive		Commercial	174.05282342	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	138-59-0	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H4_n.mzXML	*.*	3,4 DIHYDROXYMANDELATE	183.02989735600002	Orbitrap	ESI	21	OC(C(O)=O)C1=CC=C(O)C(O)=C1	InChI=1S/C8H8O5/c9-5-2-1-4(3-6(5)10)7(11)8(12)13/h1-3,7,9-11H,(H,12,13)	N/A	-1	Negative		Commercial	184.037173356	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	775-01-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F3_p.mzXML	*.*	D-GLUCURONOLACTONE	199.021305976	Orbitrap	ESI	25	O[C@@H]1O[C@@H]2[C@@H](O)C(=O)O[C@@H]2[C@H]1O	InChI=1S/C6H8O6/c7-1-3-4(12-5(1)9)2(8)6(10)11-3/h1-5,7-9H/t1-,2-,3-,4-,5-/m1/s1	N/A	1	Positive		Commercial	176.032087976	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	32449-92-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B10_n.mzXML	*.*	PTERIN	162.04213378	Orbitrap	ESI	19	NC1=NC2=NC=CN=C2C(=O)N1	InChI=1S/C6H5N5O/c7-6-10-4-3(5(12)11-6)8-1-2-9-4/h1-2H,(H3,7,9,10,11,12)	N/A	-1	Negative		Commercial	163.04940978	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	2236-60-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G2_p.mzXML	*.*	GALACTOSAMINE	180.086648516	Orbitrap	ESI	31	C(C1C(C(C(C(O1)O)N)O)O)O	InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2	N/A	1	Positive		Commercial	179.079372516	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	1772-03-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G2_p.mzXML	*.*	GALACTOSAMINE	162.075532516	Orbitrap	ESI	26	C(C1C(C(C(C(O1)O)N)O)O)O	InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2	N/A	1	Positive		Commercial	179.079372516	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	1772-03-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G2_p.mzXML	*.*	GALACTOSAMINE	381.147963032	Orbitrap	ESI	37	C(C1C(C(C(C(O1)O)N)O)O)O	InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2	N/A	1	Positive		Commercial	179.079372516	Kelly Weldon	2M+Na	N/A	1	N/A	N/A	N/A	1772-03-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G2_p.mzXML	*.*	GALACTOSAMINE	202.068590516	Orbitrap	ESI	38	C(C1C(C(C(C(O1)O)N)O)O)O	InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2	N/A	1	Positive		Commercial	179.079372516	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	1772-03-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E1_n.mzXML	*.*	ANILINE-2-SULFONATE	172.007388084	Orbitrap	ESI	23	C1=CC=C(C(=C1)N)S(=O)(=O)O	InChI=1S/C6H7NO3S/c7-5-3-1-2-4-6(5)11(8,9)10/h1-4H,7H2,(H,8,9,10)	N/A	-1	Negative		Commercial	173.014664084	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	88-21-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E1_n.mzXML	*.*	ANILINE-2-SULFONATE	367.003994168	Orbitrap	ESI	25	C1=CC=C(C(=C1)N)S(=O)(=O)O	InChI=1S/C6H7NO3S/c7-5-3-1-2-4-6(5)11(8,9)10/h1-4H,7H2,(H,8,9,10)	N/A	-1	Negative		Commercial	173.014664084	Kelly Weldon	2M-2H+Na	N/A	1	N/A	N/A	N/A	88-21-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F10_p.mzXML	*.*	S-CARBOXYMETHYLCYSTEINE	180.032504768	Orbitrap	ESI	21	NC(CSCC(O)=O)C(O)=O	InChI=1S/C5H9NO4S/c6-3(5(9)10)1-11-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)	N/A	1	Positive		Commercial	179.025228768	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	638-23-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D6_p.mzXML	*.*	1-METHYL-L-HISTIDINE	170.09240259199998	Orbitrap	ESI	72	CN1C=NC(C[C@H](N)C(O)=O)=C1	InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1	N/A	1	Positive		Commercial	169.085126592	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	332-80-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D6_p.mzXML	*.*	1-METHYL-L-HISTIDINE	192.074344592	Orbitrap	ESI	22	CN1C=NC(C[C@H](N)C(O)=O)=C1	InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1	N/A	1	Positive		Commercial	169.085126592	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	332-80-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D12_p.mzXML	*.*	3-DEHYDROSHIKIMATE	195.026391356	Orbitrap	ESI	29	C1C(C(C(=O)C=C1C(=O)O)O)O	InChI=1S/C7H8O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1,5-6,9-10H,2H2,(H,11,12)	N/A	1	Positive		Commercial	172.037173356	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	2922-42-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H9_n.mzXML	*.*	N-ALPHA-ACETYLLYSINE	187.108816372	Orbitrap	ESI	18	CC(=O)NC(CCCCN)C(O)=O	InChI=1S/C8H16N2O3/c1-6(11)10-7(8(12)13)4-2-3-5-9/h7H,2-5,9H2,1H3,(H,10,11)(H,12,13)	N/A	-1	Negative		Commercial	188.116092372	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	1946-82-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E4_n.mzXML	*.*	SHIKIMATE	173.04554742000002	Orbitrap	ESI	21	O[C@@H]1CC(=C[C@@H](O)[C@H]1O)C(O)=O	InChI=1S/C7H10O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1,4-6,8-10H,2H2,(H,11,12)/t4-,5-,6-/m1/s1	N/A	-1	Negative		Commercial	174.05282342	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	138-59-0	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G9_n.mzXML	*.*	TYROSINE	180.066617212	Orbitrap	ESI	22	N[C@@H](CC1=CC=C(O)C=C1)C(O)=O	InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1	N/A	-1	Negative		Commercial	181.073893212	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	60-18-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G9_n.mzXML	*.*	TYROSINE	383.122452424	Orbitrap	ESI	30	N[C@@H](CC1=CC=C(O)C=C1)C(O)=O	InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1	N/A	-1	Negative		Commercial	181.073893212	Kelly Weldon	2M-2H+Na	N/A	1	N/A	N/A	N/A	60-18-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E1_p.mzXML	*.*	ANILINE-2-SULFONATE	174.021940084	Orbitrap	ESI	30	C1=CC=C(C(=C1)N)S(=O)(=O)O	InChI=1S/C6H7NO3S/c7-5-3-1-2-4-6(5)11(8,9)10/h1-4H,7H2,(H,8,9,10)	N/A	1	Positive		Commercial	173.014664084	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	88-21-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E1_p.mzXML	*.*	ANILINE-2-SULFONATE	196.003882084	Orbitrap	ESI	24	C1=CC=C(C(=C1)N)S(=O)(=O)O	InChI=1S/C6H7NO3S/c7-5-3-1-2-4-6(5)11(8,9)10/h1-4H,7H2,(H,8,9,10)	N/A	1	Positive		Commercial	173.014664084	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	88-21-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A4_n.mzXML	*.*	HISTIDINE	154.062200528	Orbitrap	ESI	23	N[C@@H](CC1=CNC=N1)C(O)=O	InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1	N/A	-1	Negative		Commercial	155.069476528	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	71-00-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A4_n.mzXML	*.*	HISTIDINE	331.113619056	Orbitrap	ESI	27	N[C@@H](CC1=CNC=N1)C(O)=O	InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1	N/A	-1	Negative		Commercial	155.069476528	Kelly Weldon	2M-2H+Na	N/A	1	N/A	N/A	N/A	71-00-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A8_n.mzXML	*.*	N-ACETYLPROLINE	156.066617212	Orbitrap	ESI	22	CC(=O)N1CCCC1C(=O)O	InChI=1S/C7H11NO3/c1-5(9)8-4-2-3-6(8)7(10)11/h6H,2-4H2,1H3,(H,10,11)	N/A	-1	Negative		Commercial	157.073893212	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	68-95-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A8_n.mzXML	*.*	N-ACETYLPROLINE	335.122452424	Orbitrap	ESI	27	CC(=O)N1CCCC1C(=O)O	InChI=1S/C7H11NO3/c1-5(9)8-4-2-3-6(8)7(10)11/h6H,2-4H2,1H3,(H,10,11)	N/A	-1	Negative		Commercial	157.073893212	Kelly Weldon	2M-2H+Na	N/A	1	N/A	N/A	N/A	68-95-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A9_n.mzXML	*.*	DIHYDROOROTATE	157.02548067200001	Orbitrap	ESI	24	OC(=O)C1CC(=O)NC(=O)N1	InChI=1S/C5H6N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h2H,1H2,(H,9,10)(H2,6,7,8,11)	N/A	-1	Negative		Commercial	158.032756672	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	5988-19-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A9_n.mzXML	*.*	DIHYDROOROTATE	337.040179344	Orbitrap	ESI	26	OC(=O)C1CC(=O)NC(=O)N1	InChI=1S/C5H6N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h2H,1H2,(H,9,10)(H2,6,7,8,11)	N/A	-1	Negative		Commercial	158.032756672	Kelly Weldon	2M-2H+Na	N/A	1	N/A	N/A	N/A	5988-19-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B10_p.mzXML	*.*	PTERIN	164.05668577999998	Orbitrap	ESI	26	NC1=NC2=NC=CN=C2C(=O)N1	InChI=1S/C6H5N5O/c7-6-10-4-3(5(12)11-6)8-1-2-9-4/h1-2H,(H3,7,9,10,11,12)	N/A	1	Positive		Commercial	163.04940978	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	2236-60-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E9_n.mzXML	*.*	N-ACETYLASPARTATE	174.04079638800002	Orbitrap	ESI	20	CC(=O)N[C@@H](CC(O)=O)C(O)=O	InChI=1S/C6H9NO5/c1-3(8)7-4(6(11)12)2-5(9)10/h4H,2H2,1H3,(H,7,8)(H,9,10)(H,11,12)/t4-/m0/s1	N/A	-1	Negative		Commercial	175.048072388	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	997-55-7	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H5_n.mzXML	*.*	PHOSPHOSERINE	184.001647606	Orbitrap	ESI	29	N[C@@H](COP(O)(O)=O)C(O)=O	InChI=1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/t2-/m0/s1	N/A	-1	Negative		Commercial	185.008923606	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	407-41-0	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A10_p.mzXML	*.*	ALLANTOIN	181.033208052	Orbitrap	ESI	36	NC(=O)NC1NC(=O)NC1=O	InChI=1S/C4H6N4O3/c5-3(10)6-1-2(9)8-4(11)7-1/h1H,(H3,5,6,10)(H2,7,8,9,11)	N/A	1	Positive		Commercial	158.043990052	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	97-59-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H8_n.mzXML	*.*	3-PHOSPHOGLYCERATE	184.985663194	Orbitrap	ESI	40	OC(COP(O)(O)=O)C(O)=O	InChI=1S/C3H7O7P/c4-2(3(5)6)1-10-11(7,8)9/h2,4H,1H2,(H,5,6)(H2,7,8,9)	N/A	-1	Negative		Commercial	185.992939194	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	80731-10-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G3_n.mzXML	*.*	CAFFEATE	179.03498273600002	Orbitrap	ESI	18	OC(=O)\C=C/C1=CC=C(O)C(O)=C1	InChI=1S/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2-	N/A	-1	Negative		Commercial	180.042258736	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	331-39-5	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C6_n.mzXML	*.*	QUINOLINATE	166.01458164000002	Orbitrap	ESI	24	OC(=O)C1=CC=CN=C1C(O)=O	InChI=1S/C7H5NO4/c9-6(10)4-2-1-3-8-5(4)7(11)12/h1-3H,(H,9,10)(H,11,12)	N/A	-1	Negative		Commercial	167.02185764	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	89-00-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C4_p.mzXML	*.*	THIOPURINE S-METHYLETHER	167.03859319199998	Orbitrap	ESI	26	CSC1=NC=NC2=C1NC=N2	InChI=1S/C6H6N4S/c1-11-6-4-5(8-2-7-4)9-3-10-6/h2-3H,1H3,(H,7,8,9,10)	N/A	1	Positive		Commercial	166.031317192	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	50-66-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C4_p.mzXML	*.*	THIOPURINE S-METHYLETHER	189.02053519199998	Orbitrap	ESI	20	CSC1=NC=NC2=C1NC=N2	InChI=1S/C6H6N4S/c1-11-6-4-5(8-2-7-4)9-3-10-6/h2-3H,1H3,(H,7,8,9,10)	N/A	1	Positive		Commercial	166.031317192	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	50-66-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E6_p.mzXML	*.*	INDOLE-3-ACETAMIDE	175.08658893999998	Orbitrap	ESI	27	OC(=N)CC1=CNC2=CC=CC=C12	InChI=1S/C10H10N2O/c11-10(13)5-7-6-12-9-4-2-1-3-8(7)9/h1-4,6,12H,5H2,(H2,11,13)	N/A	1	Positive		Commercial	174.07931294	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	879-37-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E6_p.mzXML	*.*	INDOLE-3-ACETAMIDE	371.14784388	Orbitrap	ESI	42	OC(=N)CC1=CNC2=CC=CC=C12	InChI=1S/C10H10N2O/c11-10(13)5-7-6-12-9-4-2-1-3-8(7)9/h1-4,6,12H,5H2,(H2,11,13)	N/A	1	Positive		Commercial	174.07931294	Kelly Weldon	2M+Na	N/A	1	N/A	N/A	N/A	879-37-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E6_p.mzXML	*.*	INDOLE-3-ACETAMIDE	197.06853094	Orbitrap	ESI	26	OC(=N)CC1=CNC2=CC=CC=C12	InChI=1S/C10H10N2O/c11-10(13)5-7-6-12-9-4-2-1-3-8(7)9/h1-4,6,12H,5H2,(H2,11,13)	N/A	1	Positive		Commercial	174.07931294	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	879-37-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B7_n.mzXML	*.*	3-HYDROXYMETHYLGLUTARATE	161.04554742000002	Orbitrap	ESI	19	CC(O)(CC(O)=O)CC(O)=O	InChI=1S/C6H10O5/c1-6(11,2-4(7)8)3-5(9)10/h11H,2-3H2,1H3,(H,7,8)(H,9,10)	N/A	-1	Negative		Commercial	162.05282342	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	503-49-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B7_n.mzXML	*.*	3-HYDROXYMETHYLGLUTARATE	345.08031284000003	Orbitrap	ESI	26	CC(O)(CC(O)=O)CC(O)=O	InChI=1S/C6H10O5/c1-6(11,2-4(7)8)3-5(9)10/h11H,2-3H2,1H3,(H,7,8)(H,9,10)	N/A	-1	Negative		Commercial	162.05282342	Kelly Weldon	2M-2H+Na	N/A	1	N/A	N/A	N/A	503-49-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E9_p.mzXML	*.*	N-ACETYLASPARTATE	176.055348388	Orbitrap	ESI	33	CC(=O)N[C@@H](CC(O)=O)C(O)=O	InChI=1S/C6H9NO5/c1-3(8)7-4(6(11)12)2-5(9)10/h4H,2H2,1H3,(H,7,8)(H,9,10)(H,11,12)/t4-/m0/s1	N/A	1	Positive		Commercial	175.048072388	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	997-55-7	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E9_p.mzXML	*.*	N-ACETYLASPARTATE	158.044232388	Orbitrap	ESI	37	CC(=O)N[C@@H](CC(O)=O)C(O)=O	InChI=1S/C6H9NO5/c1-3(8)7-4(6(11)12)2-5(9)10/h4H,2H2,1H3,(H,7,8)(H,9,10)(H,11,12)/t4-/m0/s1	N/A	1	Positive		Commercial	175.048072388	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	997-55-7	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E9_p.mzXML	*.*	N-ACETYLASPARTATE	198.037290388	Orbitrap	ESI	26	CC(=O)N[C@@H](CC(O)=O)C(O)=O	InChI=1S/C6H9NO5/c1-3(8)7-4(6(11)12)2-5(9)10/h4H,2H2,1H3,(H,7,8)(H,9,10)(H,11,12)/t4-/m0/s1	N/A	1	Positive		Commercial	175.048072388	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	997-55-7	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D1_p.mzXML	*.*	PYRIDOXAMINE	169.097153624	Orbitrap	ESI	26	CC1=C(O)C(CN)=C(CO)C=N1	InChI=1S/C8H12N2O2/c1-5-8(12)7(2-9)6(4-11)3-10-5/h3,11-12H,2,4,9H2,1H3	N/A	1	Positive		Commercial	168.089877624	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	524-36-7	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D1_p.mzXML	*.*	PYRIDOXAMINE	191.079095624	Orbitrap	ESI	39	CC1=C(O)C(CN)=C(CO)C=N1	InChI=1S/C8H12N2O2/c1-5-8(12)7(2-9)6(4-11)3-10-5/h3,11-12H,2,4,9H2,1H3	N/A	1	Positive		Commercial	168.089877624	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	524-36-7	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H12_n.mzXML	*.*	KYNURENATE	188.035317084	Orbitrap	ESI	22	OC(=O)C1=CC(=O)C2=CC=CC=C2N1	InChI=1S/C10H7NO3/c12-9-5-8(10(13)14)11-7-4-2-1-3-6(7)9/h1-5H,(H,11,12)(H,13,14)	N/A	-1	Negative		Commercial	189.042593084	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	492-27-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F1_p.mzXML	*.*	CITRULLINE	176.102967276	Orbitrap	ESI	26	N[C@@H](CCCNC(N)=O)C(O)=O	InChI=1S/C6H13N3O3/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)/t4-/m0/s1	N/A	1	Positive		Commercial	175.095691276	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	372-75-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F1_p.mzXML	*.*	CITRULLINE	198.084909276	Orbitrap	ESI	22	N[C@@H](CCCNC(N)=O)C(O)=O	InChI=1S/C6H13N3O3/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)/t4-/m0/s1	N/A	1	Positive		Commercial	175.095691276	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	372-75-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D11_n.mzXML	*.*	BETA-GLYCEROPHOSPHATE	171.006398638	Orbitrap	ESI	38	OCC(CO)OP(O)(O)=O	InChI=1S/C3H9O6P/c4-1-3(2-5)9-10(6,7)8/h3-5H,1-2H2,(H2,6,7,8)	N/A	-1	Negative		Commercial	172.013674638	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	154804-51-0	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G11_n.mzXML	*.*	GALACTITOL	181.07176216800002	Orbitrap	ESI	22	OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO	InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4+,5+,6-	N/A	-1	Negative		Commercial	182.079038168	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	608-66-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E7_p.mzXML	*.*	ARGININE	175.11895168799998	Orbitrap	ESI	19	N[C@@H](CCCN=C(N)N)C(O)=O	InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s1	N/A	1	Positive		Commercial	174.111675688	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	1119-34-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E7_p.mzXML	*.*	ARGININE	197.10089368799999	Orbitrap	ESI	34	N[C@@H](CCCN=C(N)N)C(O)=O	InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s1	N/A	1	Positive		Commercial	174.111675688	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	1119-34-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C5_n.mzXML	*.*	3-(2-HYDROXYPHENYL)PROPANOATE	165.05571818	Orbitrap	ESI	20	OC(=O)CCC1=CC=CC=C1O	InChI=1S/C9H10O3/c10-8-4-2-1-3-7(8)5-6-9(11)12/h1-4,10H,5-6H2,(H,11,12)	N/A	-1	Negative		Commercial	166.06299418	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	495-78-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C9_n.mzXML	*.*	PHOSPHOENOLPYRUVATE	166.97509851	Orbitrap	ESI	27	OC(=O)C(=C)OP(O)(O)=O	InChI=1S/C3H5O6P/c1-2(3(4)5)9-10(6,7)8/h1H2,(H,4,5)(H2,6,7,8)	N/A	-1	Negative		Commercial	167.98237451	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	5541-93-5	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H6_n.mzXML	*.*	O-PHOSPHOSERINE	184.001647606	Orbitrap	ESI	18	NC(COP(O)(O)=O)C(O)=O	InChI=1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)	N/A	-1	Negative		Commercial	185.008923606	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	17885-08-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H7_n.mzXML	*.*	2-PHOSPHOGLYCERATE	184.985663194	Orbitrap	ESI	26	OCC(OP(O)(O)=O)C(O)=O	InChI=1S/C3H7O7P/c4-1-2(3(5)6)10-11(7,8)9/h2,4H,1H2,(H,5,6)(H2,7,8,9)	N/A	-1	Negative		Commercial	185.992939194	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	2553-59-5	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G8_p.mzXML	*.*	THEOBROMINE	181.07200149599998	Orbitrap	ESI	26	CN1C=NC2=C1C(=O)NC(=O)N2C	InChI=1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3H,1-2H3,(H,9,12,13)	N/A	1	Positive		Commercial	180.064725496	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	83-67-0	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A2_n.mzXML	*.*	3,4-DIHYDROXYBENZOATE	153.01933267200002	Orbitrap	ESI	19	OC(=O)C1=CC(O)=C(O)C=C1	InChI=1S/C7H6O4/c8-5-2-1-4(7(10)11)3-6(5)9/h1-3,8-9H,(H,10,11)	N/A	-1	Negative		Commercial	154.026608672	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	99-50-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D2_n.mzXML	*.*	CYSTEATE	167.99721732400002	Orbitrap	ESI	65	NC(CS(O)(=O)=O)C(O)=O	InChI=1S/C3H7NO5S/c4-2(3(5)6)1-10(7,8)9/h2H,1,4H2,(H,5,6)(H,7,8,9)	N/A	-1	Negative		Commercial	169.004493324	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	23537-25-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C3_p.mzXML	*.*	PHENYLALANINE	166.086254592	Orbitrap	ESI	20	N[C@@H](CC1=CC=CC=C1)C(O)=O	InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1	N/A	1	Positive		Commercial	165.078978592	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	63-91-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B8_p.mzXML	*.*	5-HYDROXYLYSINE	163.107718308	Orbitrap	ESI	27	NC[C@H](O)CC[C@H](N)C(O)=O	InChI=1S/C6H14N2O3/c7-3-4(9)1-2-5(8)6(10)11/h4-5,9H,1-3,7-8H2,(H,10,11)/t4-,5+/m1/s1	N/A	1	Positive		Commercial	162.100442308	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	13204-98-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B8_p.mzXML	*.*	5-HYDROXYLYSINE	145.096602308	Orbitrap	ESI	33	NC[C@H](O)CC[C@H](N)C(O)=O	InChI=1S/C6H14N2O3/c7-3-4(9)1-2-5(8)6(10)11/h4-5,9H,1-3,7-8H2,(H,10,11)/t4-,5+/m1/s1	N/A	1	Positive		Commercial	162.100442308	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	13204-98-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E8_p.mzXML	*.*	N-METHYLTRYPTAMINE	175.12297444799998	Orbitrap	ESI	26	CNCCC1=CNC2=CC=CC=C12	InChI=1S/C11H14N2/c1-12-7-6-9-8-13-11-5-3-2-4-10(9)11/h2-5,8,12-13H,6-7H2,1H3	N/A	1	Positive		Commercial	174.115698448	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	61-49-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B9_p.mzXML	*.*	N-ACETYLCYSTEINE	164.037590148	Orbitrap	ESI	34	CC(=O)N[C@@H](CS)C(O)=O	InChI=1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1	N/A	1	Positive		Commercial	163.030314148	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	616-91-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G6_p.mzXML	*.*	THEOPHYLLINE	181.07200149599998	Orbitrap	ESI	26	CN1C2=C(NC=N2)C(=O)N(C)C1=O	InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)	N/A	1	Positive		Commercial	180.064725496	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	58-55-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G6_p.mzXML	*.*	THEOPHYLLINE	203.053943496	Orbitrap	ESI	20	CN1C2=C(NC=N2)C(=O)N(C)C1=O	InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)	N/A	1	Positive		Commercial	180.064725496	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	58-55-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C11_n.mzXML	*.*	URATE	167.021063988	Orbitrap	ESI	25	O=C1NC2=C(N1)C(=O)NC(=O)N2	InChI=1S/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H4,6,7,8,9,10,11,12)	N/A	-1	Negative		Commercial	168.028339988	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	69-93-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C11_n.mzXML	*.*	URATE	357.031345976	Orbitrap	ESI	30	O=C1NC2=C(N1)C(=O)NC(=O)N2	InChI=1S/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H4,6,7,8,9,10,11,12)	N/A	-1	Negative		Commercial	168.028339988	Kelly Weldon	2M-2H+Na	N/A	1	N/A	N/A	N/A	69-93-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D4_p.mzXML	*.*	NORADRENALINE	152.070053212	Orbitrap	ESI	21	NC[C@H](O)C1=CC(O)=C(O)C=C1	InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1	N/A	1	Positive		Commercial	169.073893212	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	51-41-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D4_p.mzXML	*.*	NORADRENALINE	192.063111212	Orbitrap	ESI	33	NC[C@H](O)C1=CC(O)=C(O)C=C1	InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1	N/A	1	Positive		Commercial	169.073893212	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	51-41-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D9_p.mzXML	*.*	3,4-DIHYDROXYPHENYLGLYCOL	153.0540688	Orbitrap	ESI	32	OCC(O)C1=CC(O)=C(O)C=C1	InChI=1S/C8H10O4/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8-12H,4H2	N/A	1	Positive		Commercial	170.0579088	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	28822-73-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D9_p.mzXML	*.*	3,4-DIHYDROXYPHENYLGLYCOL	193.0471268	Orbitrap	ESI	20	OCC(O)C1=CC(O)=C(O)C=C1	InChI=1S/C8H10O4/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8-12H,4H2	N/A	1	Positive		Commercial	170.0579088	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	28822-73-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E10_p.mzXML	*.*	GUANIDINOSUCCINATE	176.066581768	Orbitrap	ESI	27	NC(=N)N[C@@H](CC(O)=O)C(O)=O	InChI=1S/C5H9N3O4/c6-5(7)8-2(4(11)12)1-3(9)10/h2H,1H2,(H,9,10)(H,11,12)(H4,6,7,8)/t2-/m0/s1	N/A	1	Positive		Commercial	175.059305768	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	6133-30-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E10_p.mzXML	*.*	GUANIDINOSUCCINATE	158.055465768	Orbitrap	ESI	28	NC(=N)N[C@@H](CC(O)=O)C(O)=O	InChI=1S/C5H9N3O4/c6-5(7)8-2(4(11)12)1-3(9)10/h2H,1H2,(H,9,10)(H,11,12)(H4,6,7,8)/t2-/m0/s1	N/A	1	Positive		Commercial	175.059305768	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	6133-30-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C2_n.mzXML	*.*	RHAMNOSE	163.06119748400002	Orbitrap	ESI	23	C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O	InChI=1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3-,4+,5+,6?/m0/s1	N/A	-1	Negative		Commercial	164.068473484	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	10030-85-0	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F11_p.mzXML	*.*	HIPPURATE	180.065519148	Orbitrap	ESI	25	OC(=O)CNC(=O)C1=CC=CC=C1	InChI=1S/C9H9NO3/c11-8(12)6-10-9(13)7-4-2-1-3-5-7/h1-5H,6H2,(H,10,13)(H,11,12)	N/A	1	Positive		Commercial	179.058243148	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	495-69-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F11_p.mzXML	*.*	HIPPURATE	202.047461148	Orbitrap	ESI	32	OC(=O)CNC(=O)C1=CC=CC=C1	InChI=1S/C9H9NO3/c11-8(12)6-10-9(13)7-4-2-1-3-5-7/h1-5H,6H2,(H,10,13)(H,11,12)	N/A	1	Positive		Commercial	179.058243148	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	495-69-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C8_p.mzXML	*.*	3-METHOXYTYRAMINE	168.101904656	Orbitrap	ESI	22	COC1=C(O)C=CC(CCN)=C1	InChI=1S/C9H13NO2/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,6,11H,4-5,10H2,1H3	N/A	1	Positive		Commercial	167.094628656	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	1477-68-5	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C8_p.mzXML	*.*	3-METHOXYTYRAMINE	190.083846656	Orbitrap	ESI	36	COC1=C(O)C=CC(CCN)=C1	InChI=1S/C9H13NO2/c1-12-9-6-7(4-5-10)2-3-8(9)11/h2-3,6,11H,4-5,10H2,1H3	N/A	1	Positive		Commercial	167.094628656	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	1477-68-5	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G9_p.mzXML	*.*	TYROSINE	182.081169212	Orbitrap	ESI	19	N[C@@H](CC1=CC=C(O)C=C1)C(O)=O	InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1	N/A	1	Positive		Commercial	181.073893212	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	60-18-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C2_p.mzXML	*.*	RHAMNOSE	187.057691484	Orbitrap	ESI	19	C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O	InChI=1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3-,4+,5+,6?/m0/s1	N/A	1	Positive		Commercial	164.068473484	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	10030-85-0	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D6_n.mzXML	*.*	1-METHYL-L-HISTIDINE	168.077850592	Orbitrap	ESI	24	CN1C=NC(C[C@H](N)C(O)=O)=C1	InChI=1S/C7H11N3O2/c1-10-3-5(9-4-10)2-6(8)7(11)12/h3-4,6H,2,8H2,1H3,(H,11,12)/t6-/m0/s1	N/A	-1	Negative		Commercial	169.085126592	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	332-80-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C12_p.mzXML	*.*	3,4-DIHYDROXYPHENYLACETATE	191.031476736	Orbitrap	ESI	22	OC(=O)CC1=CC=C(O)C(O)=C1	InChI=1S/C8H8O4/c9-6-2-1-5(3-7(6)10)4-8(11)12/h1-3,9-10H,4H2,(H,11,12)	N/A	1	Positive		Commercial	168.042258736	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	102-32-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A7_p.mzXML	*.*	URACIL 5-CARBOXYLATE	157.024382608	Orbitrap	ESI	32	C1=C(C(=O)NC(=O)N1)C(=O)O	InChI=1S/C5H4N2O4/c8-3-2(4(9)10)1-6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)	N/A	1	Positive		Commercial	156.017106608	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	23945-44-0	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A7_p.mzXML	*.*	URACIL 5-CARBOXYLATE	179.006324608	Orbitrap	ESI	31	C1=C(C(=O)NC(=O)N1)C(=O)O	InChI=1S/C5H4N2O4/c8-3-2(4(9)10)1-6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)	N/A	1	Positive		Commercial	156.017106608	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	23945-44-0	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G3_p.mzXML	*.*	CAFFEATE	163.038418736	Orbitrap	ESI	21	OC(=O)\C=C/C1=CC=C(O)C(O)=C1	InChI=1S/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2-	N/A	1	Positive		Commercial	180.042258736	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	331-39-5	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E2_p.mzXML	*.*	2-QUINOLINECARBOXYLATE	174.054954464	Orbitrap	ESI	22	OC(=O)C1=NC2=CC=CC=C2C=C1	InChI=1S/C10H7NO2/c12-10(13)9-6-5-7-3-1-2-4-8(7)11-9/h1-6H,(H,12,13)	N/A	1	Positive		Commercial	173.047678464	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	93-10-7	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E2_p.mzXML	*.*	2-QUINOLINECARBOXYLATE	196.036896464	Orbitrap	ESI	28	OC(=O)C1=NC2=CC=CC=C2C=C1	InChI=1S/C10H7NO2/c12-10(13)9-6-5-7-3-1-2-4-8(7)11-9/h1-6H,(H,12,13)	N/A	1	Positive		Commercial	173.047678464	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	93-10-7	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F4_p.mzXML	*.*	SEROTONIN	177.10223900399998	Orbitrap	ESI	28	C1=CC2=C(C=C1O)C(=CN2)CCN	InChI=1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2	N/A	1	Positive		Commercial	176.094963004	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	61-47-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F4_p.mzXML	*.*	SEROTONIN	199.084181004	Orbitrap	ESI	35	C1=CC2=C(C=C1O)C(=CN2)CCN	InChI=1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2	N/A	1	Positive		Commercial	176.094963004	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	61-47-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B11_p.mzXML	*.*	2,4-DIHYDROXYPTERIDINE	165.040701368	Orbitrap	ESI	24	C1=CN=C2C(=N1)C(=O)NC(=O)N2	InChI=1S/C6H4N4O2/c11-5-3-4(8-2-1-7-3)9-6(12)10-5/h1-2H,(H2,8,9,10,11,12)	N/A	1	Positive		Commercial	164.033425368	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	487-21-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E5_p.mzXML	*.*	N-ACETYLASPARAGINE	197.0532748	Orbitrap	ESI	27	CC(=O)N[C@@H](CC(N)=O)C(O)=O	InChI=1S/C6H10N2O4/c1-3(9)8-4(6(11)12)2-5(7)10/h4H,2H2,1H3,(H2,7,10)(H,8,9)(H,11,12)/t4-/m0/s1	N/A	1	Positive		Commercial	174.0640568	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	4033-40-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G1_p.mzXML	*.*	D-MANNOSAMINE	180.086648516	Orbitrap	ESI	24	C(C1C(C(C(C(O1)O)N)O)O)O	InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2	N/A	1	Positive		Commercial	179.079372516	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	5505-63-5	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G1_p.mzXML	*.*	D-MANNOSAMINE	162.075532516	Orbitrap	ESI	22	C(C1C(C(C(C(O1)O)N)O)O)O	InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2	N/A	1	Positive		Commercial	179.079372516	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	5505-63-5	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G1_p.mzXML	*.*	D-MANNOSAMINE	202.068590516	Orbitrap	ESI	32	C(C1C(C(C(C(O1)O)N)O)O)O	InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2	N/A	1	Positive		Commercial	179.079372516	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	5505-63-5	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B3_n.mzXML	*.*	N-METHYLGLUTAMATE	160.06153183200001	Orbitrap	ESI	19	CNC(CCC(=O)O)C(=O)O	InChI=1S/C6H11NO4/c1-7-4(6(10)11)2-3-5(8)9/h4,7H,2-3H2,1H3,(H,8,9)(H,10,11)	N/A	-1	Negative		Commercial	161.068807832	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	6753-62-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D12_n.mzXML	*.*	3-DEHYDROSHIKIMATE	171.02989735600002	Orbitrap	ESI	19	C1C(C(C(=O)C=C1C(=O)O)O)O	InChI=1S/C7H8O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1,5-6,9-10H,2H2,(H,11,12)	N/A	-1	Negative		Commercial	172.037173356	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	2922-42-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D12_n.mzXML	*.*	3-DEHYDROSHIKIMATE	365.04901271200004	Orbitrap	ESI	25	C1C(C(C(=O)C=C1C(=O)O)O)O	InChI=1S/C7H8O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1,5-6,9-10H,2H2,(H,11,12)	N/A	-1	Negative		Commercial	172.037173356	Kelly Weldon	2M-2H+Na	N/A	1	N/A	N/A	N/A	2922-42-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E11_p.mzXML	*.*	INDOLE-3-ACETATE	176.070604528	Orbitrap	ESI	26	OC(=O)CC1=CNC2=C1C=CC=C2	InChI=1S/C10H9NO2/c12-10(13)5-7-6-11-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H,12,13)	N/A	1	Positive		Commercial	175.063328528	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	87-51-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E11_p.mzXML	*.*	INDOLE-3-ACETATE	198.052546528	Orbitrap	ESI	27	OC(=O)CC1=CNC2=C1C=CC=C2	InChI=1S/C10H9NO2/c12-10(13)5-7-6-11-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H,12,13)	N/A	1	Positive		Commercial	175.063328528	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	87-51-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A3_n.mzXML	*.*	HISTIDINE	154.062200528	Orbitrap	ESI	21	N[C@@H](CC1=CNC=N1)C(O)=O	InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1	N/A	-1	Negative		Commercial	155.069476528	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	5934-29-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A3_n.mzXML	*.*	HISTIDINE	331.113619056	Orbitrap	ESI	26	N[C@@H](CC1=CNC=N1)C(O)=O	InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1	N/A	-1	Negative		Commercial	155.069476528	Kelly Weldon	2M-2H+Na	N/A	1	N/A	N/A	N/A	5934-29-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F10_n.mzXML	*.*	S-CARBOXYMETHYLCYSTEINE	178.01795276800001	Orbitrap	ESI	25	NC(CSCC(O)=O)C(O)=O	InChI=1S/C5H9NO4S/c6-3(5(9)10)1-11-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)	N/A	-1	Negative		Commercial	179.025228768	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	638-23-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A7_n.mzXML	*.*	URACIL 5-CARBOXYLATE	155.00983060800002	Orbitrap	ESI	21	C1=C(C(=O)NC(=O)N1)C(=O)O	InChI=1S/C5H4N2O4/c8-3-2(4(9)10)1-6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)	N/A	-1	Negative		Commercial	156.017106608	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	23945-44-0	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B12_p.mzXML	*.*	2-DEOXY-D-GLUCOSE	187.057691484	Orbitrap	ESI	19	[H]C([H])(C=O)[C@@]([H])(O)[C@]([H])(O)[C@]([H])(O)CO	InChI=1S/C6H12O5/c7-2-1-4(9)6(11)5(10)3-8/h2,4-6,8-11H,1,3H2/t4-,5-,6+/m1/s1	N/A	1	Positive		Commercial	164.068473484	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	154-17-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G6_n.mzXML	*.*	THEOPHYLLINE	179.057449496	Orbitrap	ESI	19	CN1C2=C(NC=N2)C(=O)N(C)C1=O	InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)	N/A	-1	Negative		Commercial	180.064725496	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	58-55-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G6_n.mzXML	*.*	THEOPHYLLINE	381.104116992	Orbitrap	ESI	27	CN1C2=C(NC=N2)C(=O)N(C)C1=O	InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)	N/A	-1	Negative		Commercial	180.064725496	Kelly Weldon	2M-2H+Na	N/A	1	N/A	N/A	N/A	58-55-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H10_n.mzXML	*.*	10-HYDROXYDECANOATE	187.1339685	Orbitrap	ESI	18	C(CCCCC(=O)O)CCCCO	InChI=1S/C10H20O3/c11-9-7-5-3-1-2-4-6-8-10(12)13/h11H,1-9H2,(H,12,13)	N/A	-1	Negative		Commercial	188.1412445	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	1679-53-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G7_p.mzXML	*.*	PARAXANTHINE	181.07200149599998	Orbitrap	ESI	26	CN1C=NC2=C1C(=O)N(C)C(=O)N2	InChI=1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)11(2)7(13)9-5/h3H,1-2H3,(H,9,13)	N/A	1	Positive		Commercial	180.064725496	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	611-59-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E12_p.mzXML	*.*	INDOLE-3-ACETATE	176.070604528	Orbitrap	ESI	26	OC(=O)CC1=CNC2=C1C=CC=C2	InChI=1S/C10H9NO2/c12-10(13)5-7-6-11-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H,12,13)	N/A	1	Positive		Commercial	175.063328528	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	6505-45-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E12_p.mzXML	*.*	INDOLE-3-ACETATE	198.052546528	Orbitrap	ESI	28	OC(=O)CC1=CNC2=C1C=CC=C2	InChI=1S/C10H9NO2/c12-10(13)5-7-6-11-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H,12,13)	N/A	1	Positive		Commercial	175.063328528	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	6505-45-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G5_p.mzXML	*.*	METHIONINE SULFOXIMINE	181.064139244	Orbitrap	ESI	27	CS(=N)(=O)CCC(N)C(O)=O	InChI=1S/C5H12N2O3S/c1-11(7,10)3-2-4(6)5(8)9/h4,7H,2-3,6H2,1H3,(H,8,9)	N/A	1	Positive		Commercial	180.056863244	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	15985-39-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B11_n.mzXML	*.*	2,4-DIHYDROXYPTERIDINE	163.026149368	Orbitrap	ESI	18	C1=CN=C2C(=N1)C(=O)NC(=O)N2	InChI=1S/C6H4N4O2/c11-5-3-4(8-2-1-7-3)9-6(12)10-5/h1-2H,(H2,8,9,10,11,12)	N/A	-1	Negative		Commercial	164.033425368	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	487-21-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C1_n.mzXML	*.*	FUCOSE	163.06119748400002	Orbitrap	ESI	25	C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O	InChI=1S/C6H12O5/c1-2-3(7)4(8)5(9)6(10)11-2/h2-10H,1H3/t2-,3+,4+,5-,6?/m0/s1	N/A	-1	Negative		Commercial	164.068473484	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	2438-80-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F11_n.mzXML	*.*	HIPPURATE	178.050967148	Orbitrap	ESI	21	OC(=O)CNC(=O)C1=CC=CC=C1	InChI=1S/C9H9NO3/c11-8(12)6-10-9(13)7-4-2-1-3-5-7/h1-5H,6H2,(H,10,13)(H,11,12)	N/A	-1	Negative		Commercial	179.058243148	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	495-69-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C6_p.mzXML	*.*	QUINOLINATE	168.02913364	Orbitrap	ESI	32	OC(=O)C1=CC=CN=C1C(O)=O	InChI=1S/C7H5NO4/c9-6(10)4-2-1-3-8-5(4)7(11)12/h1-3H,(H,9,10)(H,11,12)	N/A	1	Positive		Commercial	167.02185764	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	89-00-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C6_p.mzXML	*.*	QUINOLINATE	150.01801764	Orbitrap	ESI	33	OC(=O)C1=CC=CN=C1C(O)=O	InChI=1S/C7H5NO4/c9-6(10)4-2-1-3-8-5(4)7(11)12/h1-3H,(H,9,10)(H,11,12)	N/A	1	Positive		Commercial	167.02185764	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	89-00-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D1_n.mzXML	*.*	PYRIDOXAMINE	167.082601624	Orbitrap	ESI	22	CC1=C(O)C(CN)=C(CO)C=N1	InChI=1S/C8H12N2O2/c1-5-8(12)7(2-9)6(4-11)3-10-5/h3,11-12H,2,4,9H2,1H3	N/A	-1	Negative		Commercial	168.089877624	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	524-36-7	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F6_n.mzXML	*.*	N-FORMYL-L-METHIONINE	176.038688212	Orbitrap	ESI	24	CSCC[C@@H](NC=O)C(O)=O	InChI=1S/C6H11NO3S/c1-11-3-2-5(6(9)10)7-4-8/h4-5H,2-3H2,1H3,(H,7,8)(H,9,10)/t5-/m1/s1	N/A	-1	Negative		Commercial	177.045964212	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	4289-98-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F6_n.mzXML	*.*	N-FORMYL-L-METHIONINE	375.066594424	Orbitrap	ESI	27	CSCC[C@@H](NC=O)C(O)=O	InChI=1S/C6H11NO3S/c1-11-3-2-5(6(9)10)7-4-8/h4-5H,2-3H2,1H3,(H,7,8)(H,9,10)/t5-/m1/s1	N/A	-1	Negative		Commercial	177.045964212	Kelly Weldon	2M-2H+Na	N/A	1	N/A	N/A	N/A	4289-98-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D3_p.mzXML	*.*	PYRIDOXINE	170.081169212	Orbitrap	ESI	19	CC1=NC=C(CO)C(CO)=C1O	InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3	N/A	1	Positive		Commercial	169.073893212	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	65-23-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D3_p.mzXML	*.*	PYRIDOXINE	152.070053212	Orbitrap	ESI	20	CC1=NC=C(CO)C(CO)=C1O	InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3	N/A	1	Positive		Commercial	169.073893212	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	65-23-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D3_p.mzXML	*.*	PYRIDOXINE	192.063111212	Orbitrap	ESI	25	CC1=NC=C(CO)C(CO)=C1O	InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3	N/A	1	Positive		Commercial	169.073893212	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	65-23-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D3_p.mzXML	*.*	PYRIDOXINE	134.060029212	Orbitrap	ESI	26	CC1=NC=C(CO)C(CO)=C1O	InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3	N/A	1	Positive		Commercial	169.073893212	Kelly Weldon	M-2H2O+H	N/A	1	N/A	N/A	N/A	65-23-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D2_p.mzXML	*.*	CYSTEATE	191.993711324	Orbitrap	ESI	32	NC(CS(O)(=O)=O)C(O)=O	InChI=1S/C3H7NO5S/c4-2(3(5)6)1-10(7,8)9/h2H,1,4H2,(H,5,6)(H,7,8,9)	N/A	1	Positive		Commercial	169.004493324	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	23537-25-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H3_p.mzXML	*.*	EPINEPHRINE	184.096819276	Orbitrap	ESI	26	CNC[C@H](O)C1=CC=C(O)C(O)=C1	InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1	N/A	1	Positive		Commercial	183.089543276	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	51-43-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H3_p.mzXML	*.*	EPINEPHRINE	166.085703276	Orbitrap	ESI	19	CNC[C@H](O)C1=CC=C(O)C(O)=C1	InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1	N/A	1	Positive		Commercial	183.089543276	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	51-43-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G12_p.mzXML	*.*	4-PYRIDOXATE	184.060433768	Orbitrap	ESI	26	CC1=NC=C(CO)C(C(O)=O)=C1O	InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)	N/A	1	Positive		Commercial	183.053157768	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	82-82-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G12_p.mzXML	*.*	4-PYRIDOXATE	166.049317768	Orbitrap	ESI	19	CC1=NC=C(CO)C(C(O)=O)=C1O	InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)	N/A	1	Positive		Commercial	183.053157768	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	82-82-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G12_p.mzXML	*.*	4-PYRIDOXATE	206.042375768	Orbitrap	ESI	27	CC1=NC=C(CO)C(C(O)=O)=C1O	InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)	N/A	1	Positive		Commercial	183.053157768	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	82-82-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G12_p.mzXML	*.*	4-PYRIDOXATE	148.039293768	Orbitrap	ESI	21	CC1=NC=C(CO)C(C(O)=O)=C1O	InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)	N/A	1	Positive		Commercial	183.053157768	Kelly Weldon	M-2H2O+H	N/A	1	N/A	N/A	N/A	82-82-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E5_n.mzXML	*.*	N-ACETYLASPARAGINE	173.0567808	Orbitrap	ESI	22	CC(=O)N[C@@H](CC(N)=O)C(O)=O	InChI=1S/C6H10N2O4/c1-3(9)8-4(6(11)12)2-5(7)10/h4H,2H2,1H3,(H2,7,10)(H,8,9)(H,11,12)/t4-/m0/s1	N/A	-1	Negative		Commercial	174.0640568	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	4033-40-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H11_p.mzXML	*.*	N,N,N-TRIMETHYLLYSINE	189.15975387999998	Orbitrap	ESI	26	C[N+](C)(C)CCCC[C@H](N)C([O-])=O	InChI=1S/C9H20N2O2/c1-11(2,3)7-5-4-6-8(10)9(12)13/h8H,4-7,10H2,1-3H3/t8-/m0/s1	N/A	1	Positive		Commercial	188.15247788	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	55528-53-5	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F12_p.mzXML	*.*	GLUCOSAMINE	180.086648516	Orbitrap	ESI	28	N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O	InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6?/m1/s1	N/A	1	Positive		Commercial	179.079372516	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	66-84-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F12_p.mzXML	*.*	GLUCOSAMINE	162.075532516	Orbitrap	ESI	26	N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O	InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6?/m1/s1	N/A	1	Positive		Commercial	179.079372516	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	66-84-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_F12_p.mzXML	*.*	GLUCOSAMINE	202.068590516	Orbitrap	ESI	38	N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O	InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6?/m1/s1	N/A	1	Positive		Commercial	179.079372516	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	66-84-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A1_n.mzXML	*.*	2,3-DIHYDROXYBENZOATE	153.01933267200002	Orbitrap	ESI	19	OC(=O)C1=CC=CC(O)=C1O	InChI=1S/C7H6O4/c8-5-3-1-2-4(6(5)9)7(10)11/h1-3,8-9H,(H,10,11)	N/A	-1	Negative		Commercial	154.026608672	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	303-38-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A1_n.mzXML	*.*	2,3-DIHYDROXYBENZOATE	329.02788334400003	Orbitrap	ESI	27	OC(=O)C1=CC=CC(O)=C1O	InChI=1S/C7H6O4/c8-5-3-1-2-4(6(5)9)7(10)11/h1-3,8-9H,(H,10,11)	N/A	-1	Negative		Commercial	154.026608672	Kelly Weldon	2M-2H+Na	N/A	1	N/A	N/A	N/A	303-38-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A5_n.mzXML	*.*	OROTATE	155.00983060800002	Orbitrap	ESI	19	OC(=O)C1=CC(=O)NC(=O)N1	InChI=1S/C5H4N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)	N/A	-1	Negative		Commercial	156.017106608	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	65-86-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C7_n.mzXML	*.*	4-HYDROXY-L-PHENYLGLYCINE	166.050967148	Orbitrap	ESI	19	C1=CC(=CC=C1C(C(=O)O)N)O	InChI=1S/C8H9NO3/c9-7(8(11)12)5-1-3-6(10)4-2-5/h1-4,7,10H,9H2,(H,11,12)	N/A	-1	Negative		Commercial	167.058243148	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	32462-30-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A9_p.mzXML	*.*	DIHYDROOROTATE	159.040032672	Orbitrap	ESI	31	OC(=O)C1CC(=O)NC(=O)N1	InChI=1S/C5H6N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h2H,1H2,(H,9,10)(H2,6,7,8,11)	N/A	1	Positive		Commercial	158.032756672	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	5988-19-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A11_n.mzXML	*.*	6-CARBOXYHEXANOATE	159.06628286400002	Orbitrap	ESI	18	C(CCC(=O)O)CCC(=O)O	InChI=1S/C7H12O4/c8-6(9)4-2-1-3-5-7(10)11/h1-5H2,(H,8,9)(H,10,11)	N/A	-1	Negative		Commercial	160.073558864	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	111-16-0	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H10_p.mzXML	*.*	10-HYDROXYDECANOATE	211.1304625	Orbitrap	ESI	20	C(CCCCC(=O)O)CCCCO	InChI=1S/C10H20O3/c11-9-7-5-3-1-2-4-6-8-10(12)13/h11H,1-9H2,(H,12,13)	N/A	1	Positive		Commercial	188.1412445	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	1679-53-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H10_p.mzXML	*.*	10-HYDROXYDECANOATE	153.1273805	Orbitrap	ESI	21	C(CCCCC(=O)O)CCCCO	InChI=1S/C10H20O3/c11-9-7-5-3-1-2-4-6-8-10(12)13/h11H,1-9H2,(H,12,13)	N/A	1	Positive		Commercial	188.1412445	Kelly Weldon	M-2H2O+H	N/A	1	N/A	N/A	N/A	1679-53-4	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C4_n.mzXML	*.*	THIOPURINE S-METHYLETHER	165.024041192	Orbitrap	ESI	20	CSC1=NC=NC2=C1NC=N2	InChI=1S/C6H6N4S/c1-11-6-4-5(8-2-7-4)9-3-10-6/h2-3H,1H3,(H,7,8,9,10)	N/A	-1	Negative		Commercial	166.031317192	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	50-66-8	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G12_n.mzXML	*.*	4-PYRIDOXATE	182.04588176800002	Orbitrap	ESI	22	CC1=NC=C(CO)C(C(O)=O)=C1O	InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)	N/A	-1	Negative		Commercial	183.053157768	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	82-82-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_G12_n.mzXML	*.*	4-PYRIDOXATE	387.080981536	Orbitrap	ESI	24	CC1=NC=C(CO)C(C(O)=O)=C1O	InChI=1S/C8H9NO4/c1-4-7(11)6(8(12)13)5(3-10)2-9-4/h2,10-11H,3H2,1H3,(H,12,13)	N/A	-1	Negative		Commercial	183.053157768	Kelly Weldon	2M-2H+Na	N/A	1	N/A	N/A	N/A	82-82-6	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_E7_n.mzXML	*.*	ARGININE	173.104399688	Orbitrap	ESI	23	N[C@@H](CCCN=C(N)N)C(O)=O	InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s1	N/A	-1	Negative		Commercial	174.111675688	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	1119-34-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_C3_n.mzXML	*.*	PHENYLALANINE	164.071702592	Orbitrap	ESI	20	N[C@@H](CC1=CC=CC=C1)C(O)=O	InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1	N/A	-1	Negative		Commercial	165.078978592	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	63-91-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H1_p.mzXML	*.*	PHOSPHORYLCHOLINE	184.07332055799998	Orbitrap	ESI	26	C[N+](C)(CCOP([O-])(O)=O)C	InChI=1S/C5H14NO4P/c1-6(2,3)4-5-10-11(7,8)9/h4-5H2,1-3H3,(H-,7,8,9)	N/A	1	Positive		Commercial	183.066044558	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	72556-74-2	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H2_p.mzXML	*.*	NORMETANEPHRINE	166.085703276	Orbitrap	ESI	19	COC1=CC(=CC=C1O)C(O)CN	InChI=1S/C9H13NO3/c1-13-9-4-6(8(12)5-10)2-3-7(9)11/h2-4,8,11-12H,5,10H2,1H3	N/A	1	Positive		Commercial	183.089543276	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	1011-74-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_H2_p.mzXML	*.*	NORMETANEPHRINE	206.078761276	Orbitrap	ESI	26	COC1=CC(=CC=C1O)C(O)CN	InChI=1S/C9H13NO3/c1-13-9-4-6(8(12)5-10)2-3-7(9)11/h2-4,8,11-12H,5,10H2,1H3	N/A	1	Positive		Commercial	183.089543276	Kelly Weldon	M+Na	N/A	1	N/A	N/A	N/A	1011-74-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A6_n.mzXML	*.*	OROTATE	155.00983060800002	Orbitrap	ESI	22	OC(=O)C1=CC(=O)NC(=O)N1	InChI=1S/C5H4N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)	N/A	-1	Negative		Commercial	156.017106608	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	50887-69-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A6_n.mzXML	*.*	OROTATE	333.008879216	Orbitrap	ESI	24	OC(=O)C1=CC(=O)NC(=O)N1	InChI=1S/C5H4N2O4/c8-3-1-2(4(9)10)6-5(11)7-3/h1H,(H,9,10)(H2,6,7,8,11)	N/A	-1	Negative		Commercial	156.017106608	Kelly Weldon	2M-2H+Na	N/A	1	N/A	N/A	N/A	50887-69-9	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B2_p.mzXML	*.*	AMINOADIPATE	162.076083832	Orbitrap	ESI	26	NC(CCCC(O)=O)C(O)=O	InChI=1S/C6H11NO4/c7-4(6(10)11)2-1-3-5(8)9/h4H,1-3,7H2,(H,8,9)(H,10,11)	N/A	1	Positive		Commercial	161.068807832	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	542-32-5	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_B2_p.mzXML	*.*	AMINOADIPATE	144.064967832	Orbitrap	ESI	27	NC(CCCC(O)=O)C(O)=O	InChI=1S/C6H11NO4/c7-4(6(10)11)2-1-3-5(8)9/h4H,1-3,7H2,(H,8,9)(H,10,11)	N/A	1	Positive		Commercial	161.068807832	Kelly Weldon	M-H2O+H	N/A	1	N/A	N/A	N/A	542-32-5	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A4_p.mzXML	*.*	HISTIDINE	156.076752528	Orbitrap	ESI	27	N[C@@H](CC1=CNC=N1)C(O)=O	InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1	N/A	1	Positive		Commercial	155.069476528	Kelly Weldon	M+H	N/A	1	N/A	N/A	N/A	71-00-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_A4_p.mzXML	*.*	HISTIDINE	311.146229056	Orbitrap	ESI	98	N[C@@H](CC1=CNC=N1)C(O)=O	InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1	N/A	1	Positive		Commercial	155.069476528	Kelly Weldon	2M+H	N/A	1	N/A	N/A	N/A	71-00-1	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D9_n.mzXML	*.*	3,4-DIHYDROXYPHENYLGLYCOL	169.05063280000002	Orbitrap	ESI	20	OCC(O)C1=CC(O)=C(O)C=C1	InChI=1S/C8H10O4/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8-12H,4H2	N/A	-1	Negative		Commercial	170.0579088	Kelly Weldon	M-H	N/A	1	N/A	N/A	N/A	28822-73-3	Dorrestein
MSV000084479/peak/mzXML/GNPS00005_D9_n.mzXML	*.*	3,4-DIHYDROXYPHENYLGLYCOL	339.1085416	Orbitrap	ESI	27	OCC(O)C1=CC(O)=C(O)C=C1	InChI=1S/C8H10O4/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8-12H,4H2	N/A	-1	Negative		Commercial	170.0579088	Kelly Weldon	2M-H	N/A	1	N/A	N/A	N/A	28822-73-3	Dorrestein
